Morphic Announces Corporate Highlights and Financial
-Reported positive topline results from EMERALD-1 study of MORF-057 in ulcerative colitis- -Continued enrollment on target in EMERALD-2 Phase 2b trial...
Source: globenewswire.com
Development Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Development Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Development Program Updates Today - Breaking & Trending Today
MindMed Provides Corporate Update and 2023 Outlook
/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...
Source: prnewswire.com
MindMed Reports Third Quarter 2022 Financial Results and Business Highlights
/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...
Source: prnewswire.com